Literature DB >> 9780942

Treatment outcome in patients with craniomandibular disorders of muscular origin: a 7-year follow-up.

D Vallon1, M Nilner, B Söderfeldt.   

Abstract

The outcome of different treatment modalities after 7 years was investigated in a selected group of 50 patients with craniomandibular disorders of muscular origin. To minimize the possible effects of selection on the clinical material, the selected treatment group was compared to a consecutive group of patients in terms of age, gender, intensity/duration of pain, and socioeconomic profile. Both groups were comparable in most respects, but the selected group had a longer duration and a higher intensity of pain at baseline. There were more men in the consecutive group than in the selected group. A combined treatment approach resulted in a better outcome than single treatments. Sixty-five percent of all patients in the selected group reported improvement at the 7-year follow-up. All of the 19 patients who received counseling combined with different occlusal treatments improved. Forty-three percent of the patients treated otherwise showed improvement. Patients who were aware of stress responded better to treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9780942

Source DB:  PubMed          Journal:  J Orofac Pain        ISSN: 1064-6655


  3 in total

Review 1.  The role of psychosocial factors in temporomandibular disorders.

Authors:  G B Rollman; J M Gillespie
Journal:  Curr Rev Pain       Date:  2000

2.  Efficacy of appliance therapy on temporomandibular disorder related facial pain and mandibular mobility: a randomized controlled study.

Authors:  Preeti Agarwal Katyayan; Manish Khan Katyayan; Rupal J Shah; Ghanshyam Patel
Journal:  J Indian Prosthodont Soc       Date:  2013-09-14

Review 3.  [Clinical management of masticatory muscle pain: an update of the recommendations].

Authors:  H J Schindler; J C Türp; P Nilges; A Hugger
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.